Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice - ScienceDirect
COVID-19 mRNA booster provides additional protection, most beneficial for older adults
Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19
Pfizer (PFE), Moderna (MRNA) Covid Booster Vaccines Greenlighted by CDC Panel - Bloomberg
Third COVID-19 mRNA vaccine booster dose indicated for myelofibrosis patients
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study - The Lancet Infectious Diseases
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study | The BMJ
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis | Nature Medicine
Moderna on X: "A 50 µg #booster dose of our first bivalent booster #vaccine candidate, mRNA-1273.211, demonstrated superiority against Beta, Delta and #Omicron variants of concern one month after administration, and superiority
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose - The Hindu
Plug and Play” mRNA technology works fast, updating vaccines in months : Oregon Health News Blog
CDC - UPDATED: CDC updated booster recommendations for... | Facebook
Study backs efficacy of half-dosage mRNA booster| สำนักข่าวกรมประชาสัมพันธ์
Chinese mRNA COVID booster stronger against Omicron than Sinovac shot -trial data | Reuters
Centers for Disease Control and Prevention on LinkedIn: CDC recommends Novavax's non-mRNA booster for people ages 18 and older…
Vaccines | Free Full-Text | mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
Boosting with variant-matched vaccines: an opportunity to win the race against Omicron | Signal Transduction and Targeted Therapy
Real-World Association Between mRNA Vaccination and Infection From the Omicron Strain of SARS-CoV-2: A Population-Level Analysis - AJPM Focus
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study - The Lancet Infectious Diseases
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
